Literature DB >> 28427540

High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival.

Zulma X Yunt1, Jonathan H Chung2, Stephen Hobbs3, Evans R Fernandez-Perez1, Amy L Olson1, Tristan J Huie1, Rebecca C Keith1, William J Janssen1, Barbara L Goldstein1, David A Lynch1, Kevin K Brown1, Jeffrey J Swigris1, Joshua J Solomon4.   

Abstract

PURPOSE: Interstitial lung disease is a common extra-articular manifestation of rheumatoid arthritis (RA-ILD) and is associated with significant morbidity and mortality. However, limited data exist regarding predictors of mortality. We sought to examine the prognostic value of the high-resolution computed tomography (HRCT) patterns in patients with RA-ILD.
MATERIALS AND METHODS: RA-ILD patients with HRCT patterns of usual interstitial pneumonia (UIP) or nonspecific interstitial pneumonia (NSIP) were identified among a longitudinal cohort of individuals evaluated at National Jewish Health. A total of 158 subjects were included in the study. For each subject, the earliest available HRCT was reviewed independently by two expert thoracic radiologists blinded to clinical data. HRCT patterns were classified as demonstrating definite UIP, possible UIP, or NSIP. Kaplan-Meier curves were generated and survival was compared among the three patterns using a log rank test for trend.
RESULTS: One hundred subjects (63%) had HRCT findings classified as definite UIP, 23 (15%) as possible UIP and 35 (22%) as NSIP. No difference in survival was seen between subjects with definite UIP versus those with possible UIP. The combined group of subjects with either definite- or possible UIP had significantly worse survival than those with NSIP (log-rank p = 0.03).
CONCLUSIONS: In patients with RA-ILD, patients with either definite UIP or possible UIP have equally poor survival when compared to those with an NSIP pattern.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28427540     DOI: 10.1016/j.rmed.2017.03.027

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  20 in total

1.  Selective Sexual Dimorphisms in Musculoskeletal and Cardiopulmonary Pathologic Manifestations and Mortality Incidence in the Tumor Necrosis Factor-Transgenic Mouse Model of Rheumatoid Arthritis.

Authors:  Richard D Bell; Emily K Wu; Christopher A Rudmann; Megan Forney; Claire R W Kaiser; Ronald W Wood; Joe V Chakkalakal; Nicole D Paris; Alanna Klose; Guang-Qian Xiao; Javier Rangel-Moreno; Maria L Garcia-Hernandez; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  Arthritis Rheumatol       Date:  2019-07-22       Impact factor: 10.995

2.  Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population.

Authors:  Qiang Fu; Li Wang; Luling Li; Yifan Li; Ran Liu; Yi Zheng
Journal:  Clin Rheumatol       Date:  2018-12-07       Impact factor: 2.980

Review 3.  Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.

Authors:  Emily K Wu; Robert D Ambrosini; R Matthew Kottmann; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  Curr Rheumatol Rev       Date:  2019

Review 4.  Novel Biomarkers, Diagnostic and Therapeutic Approach in Rheumatoid Arthritis Interstitial Lung Disease-A Narrative Review.

Authors:  Alesandra Florescu; Florin Liviu Gherghina; Anca Emanuela Mușetescu; Vlad Pădureanu; Anca Roșu; Mirela Marinela Florescu; Cristina Criveanu; Lucian-Mihai Florescu; Anca Bobircă
Journal:  Biomedicines       Date:  2022-06-09

Review 5.  Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts.

Authors:  Yoel Brito; Marilyn K Glassberg; Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2017-11-09       Impact factor: 4.592

6.  Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.

Authors:  Ayodeji Adegunsoye; Justin M Oldham; Shashi K Bellam; Steven Montner; Matthew M Churpek; Imre Noth; Rekha Vij; Mary E Strek; Jonathan H Chung
Journal:  Ann Am Thorac Soc       Date:  2019-05

7.  Prevalence and Effects of Emphysema in Never-Smokers with Rheumatoid Arthritis Interstitial Lung Disease.

Authors:  Joseph Jacob; Jin Woo Song; Hee-Young Yoon; Gary Cross; Joseph Barnett; Wen Ling Woo; Fern Adams; Maria Kokosi; Anand Devaraj; Elisabetta Renzoni; Toby M Maher; Dong Soon Kim; Athol U Wells
Journal:  EBioMedicine       Date:  2018-01-31       Impact factor: 8.143

8.  The challenges in classifying rheumatoid arthritis-associated interstitial lung disease.

Authors:  Hanna Nurmi; Riitta Kaarteenaho
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 2.895

Review 9.  Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD.

Authors:  John N Shumar; Abhimanyu Chandel; Christopher S King
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

10.  Long-term clinical course and outcome in patients with primary Sjögren syndrome-associated interstitial lung disease.

Authors:  Yun Jae Kim; Jooae Choe; Ho Jeong Kim; Jin Woo Song
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.